Abstract 4-Hydroxynonenal (4-HNE) mediates many pathological effects of oxidative and electrophilic stress and signals to activate cytoprotective gene expression regulated by NF-
Introduction
Oxidative stress and mitochondrial dysfunction, which can ultimately produce cell death through apoptosis or necrosis, have been implicated in the etiologies of many cardiovascular diseases [1] [2] [3] [4] [5] [6] [7] [8] . Oxidative stress usually arises from overproduction of reactive oxygen species (ROS) which in turn catalytically oxidize lipids and produce highly reactive products such as the a,b-unsaturated aldehydes: 4-HNE, acrolein, and malondialdehyde [reviewed in [9] . 4-HNE is a highly reactive electrophile and forms protein and DNA adducts that are frequently detected in cardiac cells undergoing oxidative stress [10] [11] [12] .
Besides its damaging effects, 4-HNE is an important signaling molecule at physiological levels [13] and participates in the activation of several key stress kinases [14] [15] [16] and the transcription factor Nrf2 (NF-E2-related factor 2) [reviewed in [17] . Nrf2 binds cis-acting DNA sequences called antioxidant response elements (AREs; also called electrophile response elements, EpREs) to induce stressresponsive gene activity and specifically regulates genes responsible for countering oxidative and electrophilic stress. Nrf2 is bound in the cytosol by its repressor, the Kelch-like ECH-associating protein 1 (Keap1) which functions as an adaptor for a Cullin 3 (Cul3)-based E3 ubiquitin ligase, a scaffold protein for the ubiquitination and degradation of Nrf2 [18] . Keap1 regulates the degradation of Nrf2 in response to oxidants and electrophiles. Electrophiles, including 4-HNE, modify Keap1, causing it to dissociate from Nrf2 in the cytoplasm. Upon activation, Nrf2 translocates from the cytoplasm to the nucleus and binds to AREs, regulating selective gene transcription. The Keap1-Nrf2 pathway is involved in the regulation of most known genes responsible for ROS and 4-HNE disposition in different cell types, including cardiomyocytes [19] [20] [21] .
Conjugation with glutathione by glutathione transferases (GSTs) is probably the predominant course of 4-HNE disposition in most vertebrate tissues [22] . Previously, glutathione transferase alpha 4 (GSTA4-4) was shown to be abundantly expressed in protein extracts from whole mouse hearts [23] and to be localized within both the mitochondria and cytosol of mouse liver cells [24] . A study of the human heart showed uniform staining of cardiomyocytes with a GSTA4-4 antibody [25] .
To examine the regulation of electrophilic and oxidative stress in vivo, we generated a Gsta4-null mouse in the 129/ sv background. As expected, 4-HNE-conjugating activities were decreased in the tissues examined [23] , including the heart. Only 23 % of wild-type (WT) 4-HNE-conjugating activity remained in the heart of Gsta4-null mice, clearly indicating that GSTA4-4 is the major GST disposing of 4-HNE in this critical tissue. Surprisingly, no cardiac pathology was detected in Gsta4-null mice.
In this study, we examined the biochemical basis for the cardiac phenotype of the Gsta4-null mouse. Despite highly reduced 4-HNE-conjugating activity in the hearts of Gsta4-null mice, we found no difference in cardiac 4-HNE levels between WT and null mice. We also observed a higher level of nuclear Nrf2 activity and increased expression of specific Nrf2 target genes in hearts of Gsta4-null mice. We hypothesized that a Nrf-2-driven compensatory mechanism might provide a responsive defense against further oxidative and electrophilic stress. Doxorubicin (DOX) is a very effective anti-tumor drug that is known to be cardiotoxic, primarily by inducing mitochondrial dysfunction and ensuing pathology [26] [27] [28] [29] [30] [31] [32] . Specifically, as DOX trapped in cardiomyocyte mitochondria is transformed, high levels of superoxide and hydrogen peroxide are generated by redox cycling in mitochondria and the sarcoplasmic reticulum. Superoxide anion is also generated by DOX binding to endothelial nitric oxide synthase (eNOS). Both cardiomyocytes and endothelial cells are targets of DOX-induced apoptosis activated by increased ROS, oxidative stress, and ensuing lipid peroxidation. DOX also reduces intracellular levels of antioxidants and inhibits cardiac antioxidant enzymes. Hence, we challenged WT control and Gsta4-null mice with DOX: our findings suggest that Gsta4-null mice have an activated Nrf2-regulated defense mechanism in cardiac tissue that maintains steadystate levels of 4-HNE and may provide a form of preconditioning as a defense against DOX-induced cardiomyopathy involving redox changes.
Materials and Methods

Reagents and Kits
The dimethylacetal ester of 4-hydroxy-2-transnonenal was synthesized according to Gree et al. [33] , and Chandra and Srivastava [34] and stored at -80°C. Fresh 4-HNE was prepared before the assay by acid hydrolysis (pH 3.0) of the dimethylacetal ester. The Extract-N-Amp Tissue PCR Kit, butylated hydroxytoluene (BHT), NADH, and doxorubicin were purchased from Sigma (St. Louis, MO). TRIzol Reagent, the Biotech LPO-586 Kit, the QuantiTect Reverse Transcription Kit, the FastStart SYBR Green Master mix, the TransAM Nrf2 Kit, the Amplex Red Catalase Assay Kit 
Animals
The methods used to disrupt the Gsta4 gene were described previously [23] . The resulting Gsta4-null mice in the 129/ sv genetic background and matching WT mice in the same background were used for all experiments reported here. The genotype of mice with regard to the mGsta4 gene was confirmed by PCR using tail biopsy samples [23] . The work was performed in accordance with a protocol approved by the Central Arkansas Veterans Healthcare System Institutional Animal Care and Use Committee. Animals were housed in the Veterinary Medical Unit at the Central Arkansas Veterans Healthcare System in Little Rock, Arkansas.
Determination of 4-HNE Levels
Tissues harvested from 16-week-old male WT and Gsta4-null mice were quick-frozen in liquid nitrogen using Wollenberger tongs [35] and stored at -75°C until use. 4-HNE levels in liver and heart samples from 16-week-old male WT and Gsta4-null mice were determined using the Biotech LPO-586 Kit according to the manufacturer's protocol with slight modifications [36] . A 20 % (w/v) tissue homogenate was prepared in 20 mM Tris-HCl, pH 7.4, containing 5 mM BHT. The homogenates were centrifuged at 3,0009g for 15 min, and 0.2 ml of the supernatants was used for each determination. To each sample, 650 ll of N-methyl-2-phenylindole and 150 ll of either 12 N HCl (for MDA determination) or 15.4 M methanesulfonic acid (for 4-HNE plus MDA determination) were added. The reaction mixtures were vortexed and incubated at 45°C for 60 min. After centrifugation at 15,0009g for 10 min, the absorbance of the supernatants was determined at 586 nm.
Measurement of Active Nrf2 Binding
Hearts harvested from 16-week-old male WT and Gsta4-null mice were quick-frozen in liquid nitrogen using Wollenberger tongs and stored at -75°C. The level of active nuclear Nrf2 protein was determined by competitive ELISA, as previously described [37] using the TransAM Nrf2 Kit according to the manufacturer's instructions. Briefly, nuclear extracts were prepared, and contamination with cytosolic proteins was tested by western blotting for cytoplasmic actin using a monoclonal antibody against the actin C-terminus. Within the detection limits of the method, no cytosolic contamination was found in nuclei prepared from heart tissue (data not shown). Nuclear extracts (10 lg protein) were added to wells coated with an oligonucleotide containing the antioxidant response element (ARE) consensus sequence supplied by the TransAM Nrf2 Kit. Nrf2 specifically bound to the ARE was then revealed by adding anti-Nrf2 primary antibody. Detection of bound Nrf2 was achieved using a secondary antibody conjugated with horseradish peroxidase. Specificity of the reaction was confirmed by competition either with an ARE-containing oligonucleotide or a mutated, non-specific oligonucleotide supplied with the TransAM Nrf2 Kit. The amounts of active/bound Nrf2 were calculated after subtracting non-specific background values, determined by competition with the specific ARE oligonucleotide.
Determination of mRNA Levels by Reverse Transcription Real-Time Polymerase Chain Reaction
Total RNA was isolated from ventricular heart samples of 16-week-old male wild-type and Gsta4-null mice by the guanidinium thiocyanate method [38] , using the TRIzol Reagent. Complementary DNA was prepared with the QuantiTect Reverse Transcription Kit according to the manufacturer's directions using the supplied mixture of oligodT and random primers. Reverse transcription real-time polymerase chain reactions (RT-qPCR) were performed on a DNA Engine Opticon 2 Detection System (MJ Research, Waltham, MA) with the FastStart SYBR Green Master mix in a total volume of 20 ll containing 0.3 lM gene-specific primers. The cycling protocol was an initial denaturation at 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, 61°C for 30 s, and 72°C for 30 s. The ribosomal protein S3 (RPS3) transcript was used as a reference for normalization of Akr1b7 mRNA levels and the glyceraldehyde 3-phosphate dehydrogenase (Gapdh) transcript for normalization of Sod2, Cat, and Aldh2. Primers were as follows: Catalase (Cat) forward: 5 0 -ACCAGGGCATCAAAAACTTG-3 0 and Cat reverse: 5 0 -GCCCTGAAGCTTTTTGTCAG-3 0 for a 134-bp product; Superoxide dismutase (Sod2) forward:
0 for a 100-bp product; Aldehyde dehydrogenase 2 (Aldh2) forward:
0 for a 70-bp product; Aldo-keto reductase 1b7 (Akr1b7) forward: 5 0 -GTGAAAGCTCTGGGCATCTC-3 0 , Akr1b7 reverse: 5 0 -TGTCACAGACTTGGGATCA-3 0 for a 103-bp product; ribosomal protein S3 (RPS3) forward: 5 0 -TTAC ACCAACCAGGACAGAAATC-3 0 and RPS3 reverse: 5 0 -TG GACAACTGCGGTCAACTC-3 0 for a 100-bp product; and Gapdh forward: 5 0 -CGTGTTCCTACCCCCAATGT-3 0 and Gapdh reverse: 5 0 -CGTGTTCCTACCCCCAATGT-3 0 for a 73-bp product. PCR products were positively identified by sequencing of each reaction product by the DNA Sequencing Core Facility at UAMS.
Antioxidant and Anti-electrophile Enzyme Activities in the Heart
Tissue homogenates were prepared from 16-week-old male WT and Gsta4-null mice euthanized by asphyxiation with carbon dioxide. A homogenate (10 % w/v) of quick-frozen heart tissue was prepared with 20 mM potassium phosphate, pH 7.0, 1.4 mM 2-mercaptoethanol. Homogenates were clarified by centrifugation at 15,0009g for 20 min at 4°C; and the supernatants were immediately used for activity measurements. Superoxide dismutase (SOD) activities were assayed using WST-1 (2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfo-phenyl)-2H-tetrazolium, monosodium salt) as a substrate producing a water-soluble formazan dye upon reduction with a superoxide anion. The rate of WST-1 reduction by superoxide anion is linearly related to the xanthine oxidase activity and is inhibited by SOD. The IC 50 (50 % inhibitory concentration) of SOD was determined colorimetrically. SOD-2 activity was specifically measured by inhibition of SOD-1 and SOD-3 activities, adding 1 mM sodium cyanide in the reaction. The catalase assay was performed with the Amplex Red Kit using H 2 O 2 as a substrate. In the assay, formation of resorufin was detected from reaction of any unreacted H 2 O 2 and the Amplex Red reagent (N-acetyl-3,7-dihydroxyphenoxazine) in the presence of horseradish peroxidase (HRP) [39] . Measurements of activities of aldehyde dehydrogenase (ALDH), according to Manthey and Sladek [40] and Bunting et al. [41] , and aldo-keto reductase 1 (AKR), according to Burczynski et al. [42] , respectively, were taken using 4-HNE as a substrate.
Doxorubicin Treatment and Analysis
Eight WT and 8 Gsta4-null mice (aged 12-16 weeks) were administered intra-peritoneal injections of DOX for a total dose of 20 mg/kg (60 mg/m 2 ) in 4 weekly injections of 5 mg/kg (15 mg/m 2 ). Cardiac function of treated and control animals was assessed by transthoracic echocardiography using the Vevo 770 high-resolution in vivo micro-imaging system (VisualSonics, Toronto, Canada) with an RMV 707B Scanhead (center frequency 30 MHz, frequency band 15-45 MHz, and focal length 12.7 mm). Mice were anesthetized with and maintained under isoflurane during the procedure and positioned on a heated (37°C) platform that recorded both electrocardiogram and breathing pattern; an anal probe recorded body temperature. Echocardiographic parameters were obtained from two to three short-axis M-mode recordings at the mid-left ventricular level of each mouse. Functional data on 8 WT and 8 Gsta4-null mice were obtained at 2 time points: day -1 (for baseline data) and day 21. DOX injections were administered 3 days after the first echocardiography, to allow the mice to recover, and then at 7-day intervals (day ?2, ?9, ?16, and ?23). All animals were monitored daily, recording their weight, physical appearance, and mortality.
Statistical Analysis
Data were analyzed using Excel 2007 (Microsoft, Inc., Redmond, WA) and SAS versions 9.2 and 9.3 (the SAS Institute, Cary, NC). Differences in mRNA levels were analyzed by a two-factor ANOVA of two independent experiments. Genotypes were compared by two-tailed, unpaired t tests for differences in levels of 4-HNE, enzyme activities of catalase, SOD, ALDH, and AKR, and DNAbinding activity of Nrf2. Survival was analyzed using the log-rank test and Cox regression. Cardiac function variables were analyzed via repeated measures ANOVA with post hoc contrasts to assess the group differences at each time point. p-values were statistically significant if less than 0.05, or marginally significant if between 0.05 and 0.10.
Results
4-HNE Levels in the Gsta4-null Mouse Heart
Skeletal muscle, white adipose tissue, and liver had shown a significant elevation of 4-HNE levels in Gsta4-null mice, in the 129/sv genetic background [23] . Since 4-HNE levels in the heart were not examined previously, we compared 4-HNE levels in the heart and liver of Gsta4-null and WT mice. Surprisingly, we could detect no difference in 4-HNE levels in the Gsta4-null and WT hearts, in contrast to the liver, where the 4-HNE level was at least 2.5-fold higher in null mice (Fig. 1 ).
Higher Levels of Active Nrf2 in Hearts of Gsta4-null Mice
The similar levels of free 4-HNE in WT and Gsta4-null cardiac tissue suggested a possible compensatory mechanism, whereby, in the absence of 4-HNE-conjugating activity, accumulating 4-HNE might activate the Keap1-Nrf2 pathway as a specific protective mechanism in the Gsta4-null heart. The transcription factor Nrf2 is known to regulate both ROS and 4-HNE metabolism by the activation of genes encoding anti-electrophilic and antioxidant enzymes in mammalian tissues, including the heart [20, 21, 43] . Therefore, we compared the levels of Nrf2 DNAbinding activity in cardiac nuclear extracts from WT and Gsta4-null mice. We found a 2.15-fold increase (p = 0.0002) in active Nrf2 binding in the nuclear extracts of Gsta4-null mice as compared to WT mice (Fig. 2) . Fig. 1 No difference in cardiac 4-HNE levels between wild-type and Gsta4-null mice. 4-HNE levels were determined, as previously reported [23] , in liver and cardiac tissue samples from 16-week-old male mice. The difference between the null and wild-type mice was only significant for the liver (*p = 2 9 10 -4 , n = 4) Nrf2 Target Gene Expression Enhanced Nrf2 signaling elicits upregulated expression of antioxidant enzymes and enzymes involved in 4-HNE disposition. In addition to conjugation by glutathione transferases, 4-HNE in the rodent heart is oxidized by aldehyde dehydrogenase or reduced by aldo-keto reductase (aldose reductase) [44] . We examined mRNA levels of four Nrf2 target genes by quantitative reverse transcription (qRT-PCR). In a comparison of WT and Gsta4-null mice, we found a threefold elevation in the mRNA level for Sod2, encoding the mitochondrial superoxide dismutase, a less than twofold increase in catalase mRNA level, and a minor increase in one of the aldo-keto reductase isozyme transcripts (Akr1b7) ( Table 1 ). The Aldehyde dehydrogenase 2 mRNA level, encoding a mitochondrial enzyme, decreased slightly in the Gsta4-null mouse heart (Table 1) .
To determine whether there is concomitant upregulation of antioxidant and, in particular, 4-HNE-metabolizing enzymes, we examined the enzyme activities of the corresponding Nrf2 target gene products. As shown in Fig. 3, we found significant increases in all the enzyme activities examined. Catalase activity was 12 % higher, aldo-keto reductase (AKR) and aldehyde dehydrogenase (ALDH) were 30 and 29 % higher, respectively, in Gsta4-null hearts as compared to those of WT mice. Total superoxide dismutase (SOD) activity was elevated 46 %, while mitochondrial MnSOD (SOD2) was 42 % higher and cytosolic and extracellular Cu-ZnSOD (SOD1 and 3) was 54 % higher in Gsta4-null mice.
Effects of Doxorubicin Treatment on the Gsta4-null Mouse
Although the exact mechanism of DOX-induced cardiotoxicity is complex, it is widely believed that DOX-generated reactive oxygen species (ROS) is the causative agent of cardiomyopathy [45] . Since Gsta4-null mice exhibited no cardiac phenotype under normal conditions, we challenged them with DOX, which is known to produce oxidative stress, lipid peroxidation, and, in particular, accumulation of 4-HNE in the rodent heart [26, 28, 46] . Given the common DOX treatment schedules in clinical settings for human patients, we undertook a chronic treatment for Gsta4-null and WT mice with DOX. We found that WT mice were particularly sensitive to DOX, with only 2 animals surviving the 28-day duration of the experiment (Fig. 4) . Survival analysis indicated that Gsta4-null mice had an 87 % reduction in mortality from chronic DOX exposure as compared to WT mice (hazard ratio = 0.132; log-rank p = 0.033).
When baseline cardiac function was assessed by echocardiography (Echo 1 on day 1 of the DOX treatment schedule), untreated Gsta4-null mice (aged 12-16 weeks) exhibited no defect as compared to untreated WT mice (Table 2 ). However, after three DOX injections (15 mg/kg or 45 mg/m 2 total of DOX), only the hearts of WT mice revealed decreased cardiac function (Echo 2, day 21): fractional shortening (FS) was lower as compared to both the WT baseline value (p = 0.05) and FS of DOX-treated Gsta4-null mice on the same day (p = 0.03) ( Table 2) . Stroke volume also declined significantly in DOX-treated WT mice, but only mildly and insignificantly in hearts of Gsta4-null mice. A later time point could not be included in the cardiac function analysis, due to the sharp decline in survival of the WT mice.
Discussion
The murine mGSTA4-4, like its human homolog hGSTA4-4, has a very high catalytic efficiency for glutathione conjugation of the lipid peroxidation product 4-HNE [47] and is expressed at different levels in multiple tissues [23, Fig. 2 Different levels of active nuclear Nrf2 in hearts of wild-type and Gsta4-null mice. Active Nrf2 binding was measured in nuclear extracts from whole hearts of male WT and Gsta4-null mice (16 weeks of age). Open bars: nuclear extract; hatched bars: nuclear extract ? mutated probe; cross-hatched bars: nuclear extract ? competitive ARE probe. Each bar represents the mean ± SD (n = 4); statistical significance, as shown, was evaluated by the t test 48], including the heart. We reported earlier that in Gsta4-null mice, in the 129/sv genetic background, a decrease in 4-HNE-conjugating activity and an increase in 4-HNE levels were observed in the tissues examined [23, 36] . The reduction in 4-HNE-conjugating activity in the hearts of Gsta4-null mice is particularly dramatic, with only 23 % of residual conjugating activity remaining. This residual 4-HNE-conjugating activity could be largely due to Mu-class and/or other Alpha-class GSTs. With a major loss of 4-HNE-conjugating activity, higher levels of 4-HNE could be expected in the cardiac tissue of Gsta4-null mice, as seen in other tissues. However, the levels of 4-HNE in WT and Gsta4-null hearts were essentially the same (Fig. 1 ). This could be due to upregulation of either antioxidant enzymes that limit lipid peroxidation and thus 4-HNE formation or other detoxification enzymes that dispose 4-HNE in cardiac cells [44] . Furthermore, a higher level of 4-HNE in the wild-type and Gsta4-null hearts, as compared to the liver (Fig. 1) , may reflect especially high mitochondrial abundance in cardiomyocytes, subjecting them to increased oxidative stress [49] and resulting in higher steady-state levels of 4-HNE. Expression of antioxidant and anti-electrophilic genes is largely controlled by the transcription factor Nrf2, known to induce stress-responsive gene expression, including those responsible for 4-HNE metabolism in the heart [44, 50, 51] . As previously observed, both antioxidant and antielectrophile reactions lower the concentration of 4-HNE and may constitute a negative feedback loop that stabilizes 4-HNE levels in the heart of Gsta4-null mice, possibly as a buffering mechanism to prevent 4-HNE concentration rising from protective to toxic levels [37] . We recognize that other signaling pathways (such as JNK, NFKappa-B, PPAR alpha) are likely involved and undoubtedly also modulate the expression of genes involved in tissue protection. Yet, the hypothesis that Nrf2 plays a role in the induction of gene expression in cardiac cells of the Gsta4-null mouse is particularly attractive because of the documented ability of 4-HNE to activate Nrf2 [43] . Fig. 3 Antioxidant and anti-electrophile activities in WT and Gsta4-null (KO) mice. All enzyme activities were measured in heart extracts of 16-week-old male mice as described in the ''Materials and Methods''. Each bar represents the mean ± SD (n = 4); statistical significance, as shown, was evaluated by a t test. a Catalase activity was assayed using H 2 O 2 as a substrate. b SOD enzyme activities were determined using WST1 (see ''Materials and Methods'') as a substrate. c AKR and ALDH activities were measured using 4-HNE as a substrate Fig. 4 Survival of Gsta4-null and WT mice treated with DOX. 8 WT and 8 Gsta4-null mice (male, 12-16 weeks of age) were injected weekly (indicated by arrows) with 5 mg/kg DOX for 4 weeks. Survival, analyzed using the log-rank test and Cox regression, indicated that Gsta4-null mice had a significant reduction in mortality (hazard ratio = 0.132; log-rank p = 0.033)
In this study, we observed elevated Nrf2-binding activity in the hearts of untreated Gsta-null mice, while 4-HNE was maintained at normal physiological levels. Although the increase in active Nrf2 was statistically significant, its magnitude, approximately 2.15-fold (Fig. 2) , was less than that reported for cells or animals treated with a variety of Nrf2 activators [52, 53] . Typically, activation of Nrf2 is reported in terms of an increase in nuclear Nrf2 protein levels, determined by western blotting or by immunofluorescence. However, as all nuclear Nrf2 may not be active, antibody-based assays may overestimate Nrf2 activation.
To determine whether the elevated Nrf2-binding activity in the Gsta4-null mouse heart results in increased cardiac Nrf2 signaling, we examined the products of four Nrf2 target genes (Sod2, Cat, Aldh2, and Akr1b7) whose expression is critical to oxidative and electrophilic stress responses. With one exception (Aldh2), increased mRNA levels were clearly associated with increases in enzyme activity levels, indicating that greater flux through the Nrf2 pathway has an impact on the cardiac phenotype of Gsta4-null mice. Furthermore and in particular, higher levels of mRNAs encoding catalase and SOD in the Gsta4-null mouse suggest that preventing the generation of 4-HNE by reducing oxidative stress might be more effective in maintaining physiological 4-HNE levels in the absence of the anti-electrophile enzyme, GSTA4-4.
In this study, we used DOX treatment to test in vivo the effects of elevated oxidative and electrophilic stress on the hearts of WT and Gsta4-null mice. DOX is a very effective cancer treatment drug and is still widely used despite its dose-dependent and time-dependent cardiotoxicity which leads to increased ROS levels (primarily superoxide anion and hydrogen peroxide), lipid peroxidation, and accumulation of 4-HNE in the heart [26, 28, 46] . Animal and human studies indicate that DOX induces a form of dilated cardiomyopathy that is associated with interstitial inflammation, necrotic and apoptotic cell death, ventricular remodeling, and fibrosis [32, 45] . Depending on the severity of these pathological changes, cardiac function can be compromised and lead to heart failure. In Gsta4-null mice, we did not observe any significant change in two important measures of cardiac function: fractional shortening (FS) and stroke volume (SV) ( Table 2) . We did find a typical decrease in both FS and SV in WT mice that was not accompanied by increases in LVIDd or LVPWd as features of typical dilated cardiomyopathy. However, DOX-treated WT mice exhibited a commonly observed decrease in body weight [54, 55] . Hence, from the survival analysis and two important cardiac function measures, we concluded that Gsta4-null mice were better able to resist DOX cardiotoxicity than WT mice.
Our results suggest that the higher nuclear Nrf2-binding activity in Gsta4-null mice, which helps to maintain 4-HNE at WT physiological levels by elevating at least four enzyme activities, may also contribute to preconditioning the heart in Gsta4-null mice and allow a stronger response to a DOX challenge. Recently, DOX was shown to significantly downregulate activity of the Nrf2 gene as well as many of its target genes [56] ; the authors noted that deficiencies in these gene products could have implications for both DOX cardiotoxicity and its anti-tumor activity. Previous studies have shown that overexpression of mitochondrial SOD2 (MnSOD) [57, 58] or cytoplasmic catalase [59] can protect against DOX cardiomyopathy. Yet, many clinical trials have been unsuccessful in using exogenous antioxidants to confer cardioprotection during DOX treatment. However, cardiac preconditioning is a complex phenomenon that is usually associated with protection of the heart from ischemia-reperfusion injury and involves adaptive changes in signaling pathways [60] . Various strategies have been adapted to attenuate DOX-induced cardiotoxicity by preconditioning animals and cells; these include exercise, various chemical treatments, thermal exposure, and brief ischemic episodes [61] [62] [63] [64] [65] [66] [67] . For example, preconditioning of H9c2 cardiac cells by 4-HNE has been demonstrated to induce the alpha-class GST isozyme, GSTA1-1 [68] . In another study, cardiomyocytes preconditioned with a low concentration of 4-HNE (5 lM) were resistant to higher concentrations of 4-HNE due to the activation of Nrf2 and its target genes encoding protective enzymes [43] . These studies and our in vivo findings suggest that the intracellular concentration of 4-HNE is critical for the induction of cardioprotective mechanisms.
Preconditioning of the heart through use of the 4-HNEactivated Nrf2 pathway may be particularly successful by the upregulated expression of antioxidant and antielectrophile enzymes as well as the synthesis of cellular antioxidants (such as glutathione). Additionally, since Nrf2-dependent signaling is thought to confer, in part, the protection imparted by dietary chemopreventive agents including flavones and polyphenols [69] , our study supports approaches that enhance the efficacy of these chemopreventive agents to prevent cardiotoxicity when used as an adjuvant to cancer chemotherapy.
